TALIS BIOMEDICAL CORP - COM (TLIS)

CUSIP: 87424L108

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / COM
Total 13F shares
3,348,372
Share change
-8,409,730
Total reported value
$1,606,865
Price per share
$0.48
Number of holders
19
Value change
-$4,120,884
Number of buys
7
Number of sells
11

Quarterly Holders Quick Answers

What is CUSIP 87424L108?
CUSIP 87424L108 identifies TLIS - TALIS BIOMEDICAL CORP - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of TALIS BIOMEDICAL CORP - COM (TLIS) as of Q2 2023

As of 30 Jun 2023, TALIS BIOMEDICAL CORP - COM (TLIS) was held by 19 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,348,372 shares. The largest 10 holders included GREENLIGHT CAPITAL INC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, BlackRock Inc., MORGAN STANLEY, RENAISSANCE TECHNOLOGIES LLC, TWO SIGMA SECURITIES, LLC, STATE STREET CORP, and DEUTSCHE BANK AG\. This page lists 19 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.